0001562180-23-000409.txt : 20230113 0001562180-23-000409.hdr.sgml : 20230113 20230113161932 ACCESSION NUMBER: 0001562180-23-000409 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230111 FILED AS OF DATE: 20230113 DATE AS OF CHANGE: 20230113 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Obenshain Andrew CENTRAL INDEX KEY: 0001839697 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35966 FILM NUMBER: 23528998 MAIL ADDRESS: STREET 1: C/O BLUEBIRD BIO, INC. STREET 2: 455 GRAND UNION BOULEVARD CITY: SOMERVILLE STATE: MA ZIP: 02145 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: bluebird bio, Inc. CENTRAL INDEX KEY: 0001293971 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 455 GRAND UNION BOULEVARD CITY: SOMERVILLE STATE: MA ZIP: 02145 BUSINESS PHONE: 339-499-9300 MAIL ADDRESS: STREET 1: 455 GRAND UNION BOULEVARD CITY: SOMERVILLE STATE: MA ZIP: 02145 FORMER COMPANY: FORMER CONFORMED NAME: Genetix Pharmaceuticals Inc DATE OF NAME CHANGE: 20040616 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2023-01-11 false 0001293971 bluebird bio, Inc. BLUE 0001839697 Obenshain Andrew C/O BLUEBIRD BIO, INC. 455 GRAND UNION BOULEVARD SOMERVILLE MA 02145 true true false false President and CEO Common Stock 2023-01-11 4 S false 3178.00 7.8043 D 242690.00 D Shares were sold to cover tax withholding obligations incurred in connection with the vesting of Restricted Stock Units. The range in prices for the transaction reported on this line was $7.61 to $7.93. The average weighted price was $7.8043. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. /s/ Andrew Obenshain 2023-01-13